These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15293370)

  • 61. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
    Poole-Wilson PA; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Metra M; J Remme W; Swedberg K; Torp-Pedersen C
    Eur J Heart Fail; 2002 Jun; 4(3):321-9. PubMed ID: 12034158
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
    Cleland JG
    Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The carvedilol or metoprolol European trial.
    Meyer TE
    Curr Cardiol Rep; 2004 May; 6(3):198-9. PubMed ID: 15075055
    [No Abstract]   [Full Text] [Related]  

  • 65. [COPD patients with heart failure: no concern about the beta blocker!].
    Stiefelhagen P
    MMW Fortschr Med; 2012 Apr; 154(6):26. PubMed ID: 22642023
    [No Abstract]   [Full Text] [Related]  

  • 66. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Economic analysis of the treatment of heart failure with beta-blockers].
    Díez-Manglano J
    Med Clin (Barc); 2013 Sep; 141(6):265-70. PubMed ID: 23597957
    [No Abstract]   [Full Text] [Related]  

  • 68. Beta-blockers and spironolactone in heart failure.
    Kukin ML
    Curr Cardiol Rep; 2000 Mar; 2(2):87-9. PubMed ID: 10980877
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-blocker benefit according to severity of heart failure.
    Bouzamondo A; Hulot JS; Sanchez P; Lechat P
    Eur J Heart Fail; 2003 Jun; 5(3):281-9. PubMed ID: 12798825
    [TBL] [Abstract][Full Text] [Related]  

  • 70. β-Blockers in heart failure: benefits of β-blockers according to varying male proportions of study patients.
    He YM; Yang XJ; Zhao X; Cheng XJ; Xu HF; Qian YX; Li X
    Clin Cardiol; 2012 Aug; 35(8):505-11. PubMed ID: 22488122
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of beta-blockers on health-related quality of life in patients with heart failure.
    Reddy P; Dunn AB
    Pharmacotherapy; 2000 Jun; 20(6):679-89. PubMed ID: 10853624
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of beta-blockers on mortality in chronic heart failure.
    Hart SM
    Ann Pharmacother; 2000 Dec; 34(12):1440-51. PubMed ID: 11144703
    [TBL] [Abstract][Full Text] [Related]  

  • 75. AVID and COMET.
    Liebson PR; ;
    Prev Cardiol; 2003; 6(4):218-20. PubMed ID: 14605516
    [No Abstract]   [Full Text] [Related]  

  • 76. The importance of beta blockers in the treatment of heart failure.
    Chavey WE
    Am Fam Physician; 2000 Dec; 62(11):2453-62. PubMed ID: 11130231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.
    Vardeny O; Nicholas G; Andrei A; Buhr KA; Hermanson MP; Moran JJ; Detry MA; Stein JH
    Am J Hypertens; 2012 Aug; 25(8):920-6. PubMed ID: 22647787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Beta-blockers in the treatment of chronic heart failure. How should results of clinical studies be introduced into clinical practice].
    Vítovec J; Spinar J
    Vnitr Lek; 2000 Mar; 46(3):161-5. PubMed ID: 11048519
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Beta-blockers in chronic heart failure.
    Stoschitzky K
    Eur Heart J; 2002 Mar; 23(5):426; author reply 426-7. PubMed ID: 11846503
    [No Abstract]   [Full Text] [Related]  

  • 80. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
    Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
    J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.